SOLB Solvay SA

Solvay successfully completes divestment of Ionquest® 290 and OPA business lines to Italmatch Chemicals

Solvay announced today that it has sold its Ionquest® 290 solvent extraction product line used in mining applications and its octylphosphonic acid (OPA) product lines to Italmatch Chemicals. With this sale Solvay satisfies all remaining obligations set forth by the European Union regarding the approval of its acquisition last year of Cytec Industries.

“We are confident that Italmatch’s expertise and commitment to its customers will ensure that the Ionquest® 290 and OPA businesses will continue to thrive and meet the market’s needs,” commented Michael J. Radossich, President, Solvay Technology Solutions global business unit. “Customer satisfaction and a seamless transition have always been our main focus and priority in this process.”

Solvay will continue to invest in and grow its remaining mining solutions portfolio. The sale is expected to close before the end of the quarter pending customary requirements and regulatory review.

FOLLOW US ON TWITTER @SOLVAYGROUP

An international chemical and advanced materials company, Solvay assists its customers in innovating, developing and delivering high-value, sustainable products and solutions which consume less energy and reduce CO2 emissions, optimize the use of resources and improve the quality of life. Solvay serves diversified global end markets, including automotive and aerospace, consumer goods and healthcare, energy and environment, electricity and electronics, building and construction as well as industrial applications. Solvay is headquartered in Brussels with about 30,900 employees spread across 53 countries. It generated pro forma net sales of € 12.4 bn in 2015, with 90% made from activities where it ranks among the world’s top 3 players. Solvay SA (SOLB.BE) is listed on Euronext in Brussels and Paris (Bloomberg: SOLB.BB - Reuters: SOLB.BR).

EN
19/09/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Solvay SA

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

CFE: Preview: underlying 2026 margin to improve / DEME: Preview: strong 2025, eyes on 2026 outlook / JDE Peet's: Acquisition by KDP expected to close in 2Q26 / Solvay: 2025 ends with strong FCF; 2026F und. EBITDA guidance slightly below, supported by one-off / UCB: Peer Moonlake investor day / Vastned: Beat on bottom line with operational metrics accelerating, but outlook remains weak

Mathijs Geerts Danau ... (+4)
  • Mathijs Geerts Danau
  • Michiel Declercq
  • Thibault Leneeuw
  • Wim Hoste
Wim Hoste
  • Wim Hoste

Solvay FIRST LOOK: 4Q25 soft but in line with consensus, cautious FY26...

4Q uEBITDA dropped by c. 30% organ. and was in line with CSS and c. 5% below our forecast. FY26 uEBITDA guidance of € 770-850m represents a 4-13% y/y decline and is at midpoint c. 2% below consensus and 7% below our forecast. The dividend policy (stable to increasing from a € 2.43 base) looks increasingly generous as the FY26 FCF will not be enough to service the dividend and will hence push up leverage from the current 1.8x. Despite the attractive dividend yield (c 9%), the tough market conditi...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch